Bern, Bern, Switzerland Related Funds
| Fund Name | Location |
| Altur Investissement | France, Ile-de-France, Paris |
| Black Sea Trade & Development Bank | Greece, Thessaloniki, Thessaloníki |
| Dahong Group | China, Henan, Kaifeng |
| Deutsche Venture Capital | Bayern, Germany, München |
| Hangzhou Mingzeda Investment Management | China, Hangzhou, Zhejiang |
| Kayon Partners | New City, New York, United States |
| Ministry of Economic Development - Italy | - |
| Mount Independence Investments | Lexington, Massachusetts, United States |
| Park Avenue Equity Partner | New York, New York, United States |
| Prospect Hill Growth Partners | Massachusetts, United States, Waltham |
| Ranch Ventures | California, San Francisco, United States |
| Shanghai Xiawang Shangwu Zixun Hehuo Qiye | China, Shanghai |
| Techstars Bangalore Accelerator | Bangalore, India, Karnataka |
| Techstars Energy Accelerator in Partnership with Statoil | Norway, Oslo |
| Tokyu Accelerate Program | Chiyoda, Japan |
| Vallis Capital Partners | Brazil, Rio Grande do Sul, Viamão |
| Vivant | Australia, New South Wales, Sydney |
| Youxuepai | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
T3 Pharmaceuticals | 23 Nov 2016 | Basel, Basel-City, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
T3 Pharmaceuticals | 23 Nov 2016 | Basel, Basel-City, Switzerland |
